Lance Little became the Managing Director, Region Asia Pacific for Roche Diagnostics in 2012. Prior to that, he was the Managing Director of Roche Diagnostics India, where he was also the head of the wider Indian sub-region, which includes the neighbouring markets of Bangladesh, Bhutan, Nepal and Sri Lanka.
Prior to this, his experience as Managing Director extended to both Roche Diagnostics Thailand and Roche Diagnostics New Zealand. Lance joined Roche in 1995 in the technical support and management division of Boehringer Mannheim's Clinical Chemistry portfolio, before moving on to sales and marketing.
As Head of Roche's Laboratory Systems Business in New Zealand from 2002 to 2008, Lance oversaw the strategic growth of its Centralised Laboratory as well as Roche Applied Science businesses. He was appointed Managing Director of Roche Diagnostics Thailand in 2008, before returning to New Zealand to take up the role of Managing Director in 2009.
Lance started his career as a Medical Laboratory Scientist, specialising in Biochemistry at the Auckland Hospital Laboratory in New Zealand. Following this, he spent some time managing the Automation Laboratory at Diagnostic Laboratories in Auckland.
He graduated from Auckland University of Technology with a degree in Medical Laboratory Science with a specialisation in Clinical Biochemistry.
Casi la mitad de la población mundial no tiene acceso a los diagnósticos más básicos. Para alcanzar el objetivo de la ONU de 2030 de atención sanitaria para todos, esto debe cambiar.
Nearly half the global population doesn't have access to the most basic diagnostics. To hit the UN's 2030 goal of health care for all, that must change.
A proposed WHO resolution reflects a fresh global call to action to strengthen diagnostics and increase patient access for better and equal health outcomes.
A well-informed public is more willing to engage with the healthcare system, enabling preventative care and treatment that is in patients' long-term interests.
New diagnostic capabilities promise to make healthcare more personalized and pre-emptive – if the right technology and incentives are put into place
COVID-19 proves how easily infectious diseases can disrupt health systems and economies – which is why we need a new, diagnostic-centred approach to healthcare.
